blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2021021

EP2021021 - ANTHRAX COMPOSITIONS AND METHODS OF USE AND PRODUCTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.01.2012
Database last updated on 12.06.2024
Most recent event   Tooltip13.01.2012Application deemed to be withdrawnpublished on 15.02.2012  [2012/07]
Applicant(s)For all designated states
Oklahoma Medical Research Foundation
825 N.E. 13th Street
Oklahoma City, OK 73104 / US
For all designated states
Farris, Darise
16037 Teesdale Road
Edmond, OK 73013 / US
[2009/07]
Inventor(s)01 / JAMES, Judith, A.
701 N.W. 153rd Terrace
Edmond, OK 73013 / US
02 / CROWE, Sherry
3321 Pleasant Drive
Midwest City, OK 73110 / US
 [2009/07]
Representative(s)Baldock, Sharon Claire
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
[N/P]
Former [2009/07]Baldock, Sharon Claire
BOULT WADE TENNANT Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date07794875.014.05.2007
[2009/07]
WO2007US11608
Priority number, dateUS20060799819P12.05.2006         Original published format: US 799819 P
[2009/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007145760
Date:21.12.2007
Language:EN
[2007/51]
Type: A2 Application without search report 
No.:EP2021021
Date:11.02.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 21.12.2007 takes the place of the publication of the European patent application.
[2009/07]
Search report(s)International search report - published on:EP17.07.2008
ClassificationIPC:A61K39/07
[2009/07]
CPC:
G01N33/56911 (EP,US); A61K39/07 (EP,US); A61P31/04 (EP);
A61P37/04 (EP); C07K14/32 (EP,US); C07K16/1278 (EP,US);
C12Q1/6886 (EP,US); A61K2039/505 (EP,US); C07K2317/34 (EP,US);
C07K2317/76 (EP,US); G01N2333/32 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/07]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:ANTHRAX-ZUSAMMENSETZUNGEN UND VERFAHREN ZU IHRER HERSTELLUNG UND ANWENDUNG[2009/07]
English:ANTHRAX COMPOSITIONS AND METHODS OF USE AND PRODUCTION[2009/07]
French:COMPOSITIONS CONTRE L'ANTHRAX ET PROCÉDÉS D'UTILISATION ET DE PRODUCTION DE CELLES-CI[2009/07]
Entry into regional phase26.11.2008National basic fee paid 
26.11.2008Designation fee(s) paid 
26.11.2008Examination fee paid 
Examination procedure26.11.2008Amendment by applicant (claims and/or description)
26.11.2008Examination requested  [2009/07]
14.04.2011Despatch of a communication from the examining division (Time limit: M04)
23.08.2011Application deemed to be withdrawn, date of legal effect  [2012/07]
30.09.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/07]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.04.2011
Fees paidRenewal fee
26.11.2008Renewal fee patent year 03
18.05.2010Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.05.201105   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[E]WO2007131363  (CA MINISTER HEALTH & WELFARE [CA], et al) [E] 1-8,11-21 * the whole document *
 [X]  - ZHANG ET AL, "The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20060324), vol. 341, no. 4, ISSN 0006-291X, pages 1164 - 1171, XP005283009 [X] 1-8,11-21 * page 1169; table 3 * * page 1170 *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2006.01.080
 [X]  - GUBBINS MICHAEL J ET AL, "Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, (200608), vol. 47, no. 3, ISSN 0928-8244, pages 436 - 443, XP002461223 [X] 1-8,11-21 * page 439; figure 2 * * page 441 *

DOI:   http://dx.doi.org/10.1111/j.1574-695X.2006.00114.x
 [X]  - SAWADA-HIRAI RITSUKO ET AL, "Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed", JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES, BIOMED CENTRAL LTD., LONDON, GB, (20040512), vol. 2, no. 1, ISSN 1476-8518, page 5, XP021008590 [X] 16 * the whole document *

DOI:   http://dx.doi.org/10.1186/1476-8518-2-5
 [X]  - WILD M A ET AL, "HUMAN ANTIBODIES FROM IMMUNIZED DONORS ARE PROTECTIVE AGAINST ANTHRAX TOXIN IN VIVO", BIO/TECHNOLOGY, NATURE PUBLISHING CO. NEW YORK, US, (20031012), vol. 21, no. 11, ISSN 0733-222X, pages 1305 - 1306, XP008068590 [X] 16 * the whole document *
 [Y]  - LAFFLY EMMANUELLE ET AL, "Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, (200508), vol. 49, no. 8, ISSN 0066-4804, pages 3414 - 3420, XP002444247 [Y] 1-8,11-21 * the whole document *

DOI:   http://dx.doi.org/10.1128/AAC.49.8.3414-3420.2005
 [Y]  - GERDON AREN E ET AL, "Epitope mapping of the protective antigen of B. anthracis by using nanoclusters presenting conformational peptide epitopes.", ANGEWANDTE CHEMIE (INTERNATIONAL ED. IN ENGLISH) 16 JAN 2006, (20060116), vol. 45, no. 4, ISSN 1433-7851, pages 594 - 598, XP002461224 [Y] 1-8,11-21 * the whole document *

DOI:   http://dx.doi.org/10.1002/anie.200503328
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.